MSCs for Prevention of MI-induced HF
Conditions: Myocardial Infarction, Acute; Myocardial Infarction First; Myocardial Infarction, Anterior Wall; Cardiac Remodeling, Ventricular; STEMI; Regenerative Medicine; Heart Failure Interventions: Biological: Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs); Other: Conventional Treatment Sponsors: Shiraz University of Medical Sciences; National Institute of Medical Research Development (NIMAD), Iran; Cell Tech Pharmed Company, Iran Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials